Skip to main content

FDA recall, , Moderate risk

Vitalant Apheresis Platelets, Leukocytes Reduced, Pathogen Reduced

Apheresis Platelets, Leukocytes Reduced, Pathogen Reduced may have been exposed to unacceptable temperatures during an extended transit time.

Vitalant began this recall on Oct 2, 2025. FDA posted it on Nov 16, 2026, the day the recall ended.

What happened

Vitalant, a company based in Bismarck, North Dakota, is recalling Vitalant Apheresis Platelets, Leukocytes Reduced, Pathogen Reduced. The company started the recall on its own on October 2, 2025. The product was distributed in North Dakota. The FDA added the recall to its Enforcement Report and classified it on November 16, 2026.

What to do

Biologics such as blood, tissue and vaccines are usually given by hospitals and clinics. If you had a transfusion, transplant, infusion or vaccine, ask the place that treated you whether this product was used. If they contact you, follow their advice.

What was recalled

Hospitals, clinics and blood banks match these details against their records.

  1. Apheresis Platelets, Leukocytes Reduced, Pathogen Reduced

    Unit number
    • W03622515434600Z
    • W03622516525900M
    • W03622516525600S

Recall details

Posted by FDA
Recall began
Status
Ended Nov 16, 2026
Distributed to

Only in North Dakota

Recalled by
VitalantBismarck, North Dakota
Risk

Moderate risk

Its use may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

FDA event number
100030
Recall number
B-0007-2027
Recall type
Started by the company

All recalls from Vitalant

Timeline

FDA's Enforcement Report is its public list of recalls; FDA posts a recall by adding it there.

  1. Vitalant began the recall

  2. FDA posted the recall to its Enforcement Report, rated it Class II (moderate risk) and closed it

  3. Added to Recall Canary

Summary by Recall Canary, written with AI · summary updated Nov 18, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab) recall · cite: “Vitalant Apheresis Platelets, Leukocytes Reduced, Pathogen Reduced Recall.” Recall Canary. https://recallcanary.com/recall/fda/vitalant-apheresis-platelets-leukocytes-reduced-4.